Argumentation Analysis of Risk Assessments: The Case of Perfluorooctanoic Acid
W P Jongeneel1, H van Klaveren1, R P Bogers1
1National Institute of Public Health and the Environment, Bilthoven, The Netherlands.
Risk assessments for Perfluorooctanoic acid (PFOA) often lack clear reasoning for using toxicology or epidemiology data. Improved argumentation is needed for transparent health-based guidance values (HBVGs).
Area of Science:
- Environmental Science
- Toxicology
- Risk Assessment
Background:
- Chemical risk assessment relies on toxicology and epidemiology, potentially yielding different health-based guidance values (HBGVs).
- Clear communication of the rationale behind data selection is crucial for public and policymaker understanding.
- Perfluorooctanoic acid (PFOA) serves as a case study to examine argumentation in HBGV derivation.
Purpose of the Study:
- To analyze the argumentation justifying the use of toxicological versus epidemiological data in PFOA risk assessments.
- To apply pragma-dialectical argumentation theory (PDAT) to understand the reasoning behind HBGV derivations.
- To identify weaknesses in the current argumentation structures within chemical risk assessments.
Main Methods:
- Analysis of four PFOA risk assessments using pragma-dialectical argumentation theory (PDAT).
- Examination of how health endpoints and causality inferences are justified.
- Evaluation of the explicit and implicit starting points in the argumentation chains.
Main Results:
- Argumentation for data selection often relies on 'symptomatic relations' without detailing causal mechanisms.
- Underlying assumptions and causal reasoning are frequently implicit or not fully addressed.
- Decisions to include or exclude data are often based on availability, with unclear motives.
- The justification for using specific toxicological or epidemiological data is often minimally presented.
Conclusions:
- Risk assessments require more in-depth argumentation and clearer chains of reasoning to disclose the basis for HBGVs.
- Explicitly identifying and discussing the starting points of arguments can enhance risk assessment frameworks.
- Greater transparency in argumentation can lead to better utilization of toxicological and epidemiological data and more consensus.
More Related Videos
07:06Investigating Long-Distance Transport of Perfluoroalkyl Acids in Wheat via a Split-Root Exposure Technique
Published on: September 28, 2022
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Effects of Chemicals: Overview
